(Q34624681)

3 August 2017

1 reference

title

Modulation of the host response in periodontal therapy (English)

1 reference

3 August 2017

Richard J Oringer

1

1 reference

3 August 2017

Research, Science, and Therapy Committee of the American Academy of Periodontology

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Journal of Periodontology

3 August 2017

published in

1 reference

3 August 2017

volume

73

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

460-470

1 reference

Periodontal diseases: pathogenesis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Microbial etiological agents of destructive periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

A new structural class of proteasome inhibitors that prevent NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Tepoxalin blocks neutrophil migration into cutaneous inflammatory sites by inhibiting Mac-1 and E-selectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Tissue levels of bone resorptive cytokines in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Use of a soluble interleukin-1 receptor to inhibit ocular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Biological properties of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Role of matrix metalloproteinases in human periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Collagenolytic activity in amphibian tissues: a tissue culture assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Collagenolytic enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Low molecular weight inhibitors in corneal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Treating periodontal diseases by blocking tissue-destructive enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Efficacy of subantimicrobial dosing with doxycycline. Point/counterpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Bone resorption in tissue culture and its relevance to periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Suppression of Inflammation and Bone Resorption by Indomethacin During Experimental Periodontitis in Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Inhibition of alveolar bone loss in beagles with the NSAID naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Effects of topical applications of meclofenamic acid and ibuprofen on bone loss, subgingival microbiota and gingival PMN response in the primate Macaca fascicularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in Beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The effect of ketoprofen creams on periodontal disease in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Enantiospecific inhibition of ligature-induced periodontitis in beagles with topical (S)-ketoprofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Enantioselective aspects of drug action and disposition: therapeutic pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Nonsteroidal antiinflammatory drugs. Renal toxicity. Review of pediatric issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Osteoporosis: a risk factor in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The role of osteopenia in oral bone loss and periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Systemic osteoporosis and oral bone loss: evidence shows increased risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The benefits of estrogen replacement therapy on oral health. The Leisure World cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Alendronate treatment of naturally-occurring periodontitis in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Non-surgical pocket therapy: mechanical

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The interleukin-1 genotype as a severity factor in adult periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

Effects of a bisphosphonate on experimental periodontitis in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2002.73.4.460

10.1902/JOP.2002.73.4.460

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference